home / stock / dbvt / dbvt news


DBVT News and Press, DBV Technologies S.A. From 03/02/22

Stock Information

Company Name: DBV Technologies S.A.
Stock Symbol: DBVT
Market: NASDAQ
Website: dbvtechnologies.com

Menu

DBVT DBVT Quote DBVT Short DBVT News DBVT Articles DBVT Message Board
Get DBVT Alerts

News, Short Squeeze, Breakout and More Instantly...

DBVT - DBV Technologies FY 2021 Earnings Preview

DBV Technologies (NASDAQ:DBVT) is scheduled to announce FY earnings results on Thursday, March 3rd, after market close. The consensus EPS Estimate is -$0.48 (+83.7% Y/Y) and the consensus Revenue Estimate is $4.87M (-56.8% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisio...

DBVT - Notable earnings after Thursday's close

ACR, AQN, AVAV, AVGO, BCEL, CEMI, CLLS, CLXT, COO, COST, OTCPK:CURLF, DBVT, DUOL, EGLE, ENVX, EOLS, ESTC, EVFM, FCRD, FDUS, FNKO, GPS, INMB, OTCPK:MEGEF, MRVL, NCMI, ONCY, PAYO, PBYI, SIGA, SWBI, VERI, VZIO For Seeking Alpha's full earnings season calendar, click here. For further details s...

DBVT - DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022

Montrouge, France, February 24, 2022 DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmac...

DBVT - DBV Technologies to Participate in Upcoming AAAAI 2022 Congress

Montrouge, France, February 22, 2022 DBV Technologies to Participate in Upcoming AAAAI 202 2 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced ...

DBVT - DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Montrouge, France, February 14, 2022 DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conferenc e DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, ...

DBVT - Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2022

Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2022 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market: NYSE Euronext Paris ISIN C...

DBVT - Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2021

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ...

DBVT - DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 Conference

Montrouge, France, January 7, 2022 DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today...

DBVT - DBV recovers some of yesterday's losses on peanut allergy trial; shares up 13%

Shares of DBV Technologies (DBVT +13.3%) have recouped some of their losses from yesterday after the company announced a new late-stage trial for its Viaskin peanut allergy patch. The trial will evaluate a modified patch that is 50% larger than a previous version. Kempen analyst Alex Cogut to...

DBVT - VIR, VOYA and DBVT among pre market gainers

BiondVax Pharmaceuticals (NASDAQ:BVXV) +55% signs definitive agreements for development and commercialization of innovative nanosized COVID-19 antibody therapy with Max Planck Institute of Biophysical Chemistry and University Medical Center Göttingen, Germany. BioRestorative Therapi...

Previous 10 Next 10